ChroMedX Strengthens Board of Directors with the Appointment of Dr. Richard Janeczko Medical Device Investing
Kalytera Announces Initiation of Phase 2 Clinical Study in Prevention of Graft Versus Host Disease and Agreement with The Salzman Group of Israel to Manage and Partially Fund the Study to be Led by a World Class Team Cannabis Investing News
CRISPR Therapeutics Submits Clinical Trial Application for a CRISPR Gene-Edited Therapy Genetics Investing
Titan Medical Announces First Installation of SPORT Surgical System in Europe Medical Device Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
